Vincerx Pharma Files 8-K
Ticker: VINC · Form: 8-K · Filed: Jan 23, 2025 · CIK: 1796129
| Field | Detail |
|---|---|
| Company | Vincerx Pharma, Inc. (VINC) |
| Form Type | 8-K |
| Filed Date | Jan 23, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, name-change, financials
TL;DR
Vincerx Pharma filed an 8-K on Jan 23, 2025, reporting other events and financials. Formerly Vincera Pharma & LifeSci Acquisition Corp.
AI Summary
On January 23, 2025, Vincerx Pharma, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. The company was formerly known as Vincera Pharma, Inc. and LifeSci Acquisition Corp. before changing its name on December 23, 2020, and December 6, 2019, respectively.
Why It Matters
This 8-K filing indicates routine corporate updates and the submission of financial documents, suggesting ongoing operational and reporting activities for Vincerx Pharma.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report detailing corporate information and financial statements, with no immediate indication of significant new risks.
Key Players & Entities
- Vincerx Pharma, Inc. (company) — Registrant
- Vincera Pharma, Inc. (company) — Former company name
- LifeSci Acquisition Corp. (company) — Former company name
- January 23, 2025 (date) — Date of report
- 20201223 (date) — Date of name change
- 20191206 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Vincerx Pharma, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and to include 'Financial Statements and Exhibits'.
When was the report filed and what is the earliest event date reported?
The report was filed on January 23, 2025, and the earliest event date reported is also January 23, 2025.
What were the previous names of Vincerx Pharma, Inc.?
Vincerx Pharma, Inc. was formerly known as Vincera Pharma, Inc. and LifeSci Acquisition Corp.
On what dates did the company change its former names?
The company changed its name from LifeSci Acquisition Corp. on December 6, 2019, and from Vincera Pharma, Inc. on December 23, 2020.
What is the principal executive office address and phone number for Vincerx Pharma, Inc.?
The principal executive offices are located at 1825 S. Grant Street, San Mateo, California 94402, and the telephone number is (650) 800-6676.
Filing Stats: 868 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-01-23 16:10:58
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share VINC The Nasdaq
Filing Documents
- d832952d8k.htm (8-K) — 27KB
- d832952dex991.htm (EX-99.1) — 9KB
- g832952page5.jpg (GRAPHIC) — 6KB
- 0001193125-25-011456.txt ( ) — 168KB
- vinc-20250123.xsd (EX-101.SCH) — 3KB
- vinc-20250123_lab.xml (EX-101.LAB) — 18KB
- vinc-20250123_pre.xml (EX-101.PRE) — 11KB
- d832952d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 23, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 23, 2025 VINCERX PHARMA, INC. By: /s/ Raquel E. Izumi Name: Raquel E. Izumi Title: Acting Chief Executive Officer